Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9574004
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted -
US 9554563
Genetically modified mice and engraftment
granted -
US 9556277
Method of treating a TL1A-associated disease or disorder with human antibodies to TL1A
granted -
US 9550837
Therapeutic uses of anti-PCSK9 antibodies
granted -
US 9545451
Anti-PRLR antibodies and methods for killing PRLR-expressing cells
granted -
US 9546218
Anti-Tie2 antibodies and uses thereof
granted -
US 9540449
Anti-PCSK9 antibodies with pH-dependent binding characteristics
granted -
US 9532555
Humanized dipeptidyl peptidase IV (DPP4) animals
granted -
US 9533039
Methods of treating systemic lupus erythematosus (SLE) using anti-CD48 antibodies
granted -
US 9522185
Human antibodies to GFR α3 and methods of treating pain associated with osteoarthritis or bone cancer
granted -
US 9511140
Stable VEGF antagonist formulations
granted -
US 9497945
Humanized dipeptidyl peptidase IV (DPP4) animals
granted -
US 9498529
Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor
granted -
US 9475875
Anti-EGFRvIII antibodies and uses thereof
granted -
US 9475869
Human antibodies to fel d1 and methods of use thereof
granted -
US 9462794
Non-human animals having a humanized signal-regulatory protein gene
granted -
US 9453072
Anti-IL-33 antibodies
granted -
US 9447173
Human antibodies to respiratory syncytial virus F protein and methods of use thereof
granted -
US 9416167
Stable liquid formulations of dimer VEGF antagonists
granted -
US 9409990
Methods of inhibiting tumor growth by antagonizing IL-6 receptor
granted -
US 9402898
Stabilized formulations containing anti-Ang2 antibodies
granted -
US 9399674
Human antibodies to Clostridium difficile toxins
granted -
US 9371383
Anti-ASIC1 antibodies and uses thereof
granted -
US 9359437
Antibodies comprising chimeric constant domains
granted